Yingke Rui

Yingke Rui is a prominent Chinese pharmaceutical R&D enterprise specializing in the modernization of Traditional Chinese Medicine (TCM) and the development of novel drug delivery systems (NDDS). Founded in 1999, the company operates as a high-tech CRO and biotech hybrid, providing comprehensive services from drug discovery and formulation development to clinical trial management and registration. Yingke Rui is particularly recognized for its industry-leading expertise in inhalation therapies, nano-formulations, and complex topical drug delivery systems. The company maintains several specialized R&D centers across China, including dedicated facilities for nucleic acid drugs and atomized inhalation. By bridging the gap between traditional herbal medicine and modern pharmaceutical technology, Yingke Rui has successfully transferred numerous proprietary technologies to major domestic and international pharmaceutical manufacturers.